- Objectives Include Interoperability, Collaboration, Clinical Research Advancement -
SAN FRANCISCO, June 4 /PRNewswire/ -- The
"At M. D. Anderson, we concluded early in this process that interoperability of Velos with a variety of legacy institutional applications, as well as National Cancer Institute (NCI) applications and resources, was a critical success factor for our research informatics initiatives," stated Roy B. Jones, Ph.D. M.D., Professor of Medicine, Chair, Clinical Research Computing Committee, M. D. Anderson Cancer Center. "For some time, we have pushed for the implementation of SOA as the preferred way of accomplishing this goal."
Dr. Jones led efforts to form the Advisory Group, conferring with other members who are at various stages of implementing Velos eResearch to support clinical trials management. Each member has demonstrated a significant interest in a service-oriented approach to the Velos implementation. It is intended that each institution's objectives be harmonized with those of Velos and with data standards such as those in the NCI's caDSR. This will help all members achieve the goal of interoperability.
SOA is a design approach that focuses on loosely-coupled interfaces connecting multiple software agents. An SOA infrastructure enables different software applications to exchange data with one another. Using SOA principles, organizations can create new, integrated or interoperating solutions leveraging systems and databases already in place.
"We are pleased at the formation of this Advisory Group and gratified to see institutions of such high stature as its charter members," said John S. McIlwain, President and CEO of Velos. "The Velos platform will be critical to strategic directions that include collaboration with other institutions on a national and international scale. This new application layer will allow integrated systems to be more efficient and reliable. SOA is a further step in solving the 'last mile' where the value of Direct Data Capture is realized and where it will occur in real time. Velos is fully committed to developing this capability."
About The University of Texas M.D. Anderson Cancer Center
Celebrating more than six decades of Making Cancer History(R), The
Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. The company serves 21 Top 25 U.S. medical centers. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit www.velos.com.
This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.
Copyright©2009 PR Newswire.
All rights reserved